SCHEMBL2299345

SCHEMBL2299345

OC1CN(CNCCCn2ccnc2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
HSD17B10 Q99714 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
TBXAS1 P24557 1/20 0.46
QPCT Q16769 8/20 0.46
GAA P10253 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ALOX15 P16050 1/20 0.44
SOD1 P00441 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 1/20 0.43
NPC1 O15118 1/20 0.43
CYP2C19 P33261 1/20 0.42
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19786259 0.78 TBXAS1 (0.68) CYP1A2CYP3A4CYP2D6CYP2C9HSD17B10
SCHEMBL6394030 0.76 QPCT (0.53) CYP1A2CYP3A4CYP2D6CYP2C9HSD17B10
SCHEMBL2299318 0.73 TBXAS1 (0.45) TBXAS1ALDH1A1
SCHEMBL14416018 0.72 QPCT (0.59) CYP1A2CYP3A4CYP2D6CYP2C9HSD17B10
SCHEMBL8365568 0.72 TBXAS1 (0.59) CYP1A2CYP3A4CYP2D6CYP2C9HSD17B10
SCHEMBL20472308 0.71 ACHE (0.47) TBXAS1QPCTGAAKMT2A
SCHEMBL5878941 0.71 TBXAS1 (0.63) CYP1A2CYP3A4CYP2D6CYP2C9HSD17B10
SCHEMBL6342186 0.70 QPCT (0.53) CYP1A2CYP3A4CYP2D6CYP2C9HSD17B10
Hydrochloric Acid SCHEMBL20471761 0.70 ACHE (0.46) TBXAS1QPCTGAA
SCHEMBL13256613 0.70 QPCT (0.65) CYP1A2CYP3A4CYP2D6CYP2C9HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999006-B2 Anticancer agents; mitogen-activated protein kinases (MEK) EXELIXIS, INC. (US) 2011-08-16 US claimed